Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type I receptor in response to elevated interleukin-6 during pregnancy-Reference-Cited by-同舟云学术

Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type I receptor in response to elevated interleukin-6 during pregnancy

Published:2014-08 Issue:2 Volume:211 Page:158.e1-158.e6
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Amaral Lorena M.,Kiprono Luissa,Cornelius Denise C.,Shoemaker Carrie,Wallace Kedra,Moseley Janae,Wallukat Gerd,Martin James N.,Dechend Ralf,LaMarca Babbette

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference35 articles.

1. Summary of the NHLBI working group on research on hypertension during pregnancy;Roberts;Hypertension,2003

2. Mechanisms of disease: pre-eclampsia;Noris;Nat Clin Pract Nephrol,2005

3. Latest advances in understanding preeclampsia;Redman;Science,2005

4. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction;Gilbert;Am J Physiol Heart Circ Physiol,2008

5. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia;Lam;Hypertension,2005

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What now? A critical evaluation of over 20 years of clinical and research experience with 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention;American Journal of Obstetrics & Gynecology MFM;2023-10

2. Role of blood-borne factors in sympathoexcitation-mediated hypertension: Potential neurally mediated hypertension in preeclampsia;Life Sciences;2023-05

3. Immune effects of 17α-hydroxyprogesterone caproate;American Journal of Obstetrics and Gynecology;2022-10

4. 17-α Hydroxyprogesterone Caproate Immunology, a Special Focus on Preterm Labor, Preeclampsia, and COVID-19;Reproductive Medicine;2022-08-17

5. Pathophysiology and risk factors of peripartum cardiomyopathy;Nature Reviews Cardiology;2022-01-11